gemcitabine has been researched along with Pulmonary Fibrosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Pooter, C; den Hengst, W; Hendriks, J; Pauwels, P; Van den Weyngaert, D; Van Schil, P; Van Thielen, J; Wittock, A | 1 |
Hammerer, V; Pauli, G; Quoix, E; Schmitz, N | 1 |
2 other study(ies) available for gemcitabine and Pulmonary Fibrosis
Article | Year |
---|---|
Isolated lung perfusion with gemcitabine combined with radiotherapy: no additional lung toxicity in an experimental model.
Topics: Animals; Antimetabolites, Antineoplastic; Chemoradiotherapy; Chemotherapy, Cancer, Regional Perfusion; Deoxycytidine; Drug Administration Schedule; Gemcitabine; Hemosiderosis; Infusions, Intravenous; Logistic Models; Lung; Male; Models, Animal; Pulmonary Fibrosis; Random Allocation; Rats; Rats, Inbred Strains | 2012 |
[Interstitial lung disease in a patient given gemcitabine].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Deoxycytidine; Diagnosis, Differential; Disease Progression; Gemcitabine; Humans; Lung Neoplasms; Male; Neoadjuvant Therapy; Neoplasm Staging; Pulmonary Fibrosis; Tomography, X-Ray Computed | 2002 |